Advance in laboratory diagnosis of invasive fungal infection

doi:10.3969/j.issn.1673-8640.2023.02.016

Abstract

Abstract:

Invasive fungal infection has high morbidity and mortality with high cost of treatment，so the diagnosis of invasive fungal infection is important. Invasive fungal infection has similar clinical manifestations as other infections，and it is prone to misdiagnosis. There is an urgent need to improve the accurate diagnosis and treatment of invasive fungal infection. This review mainly introduces the development of clinical laboratory diagnosis of invasive fungal infection from the aspects of fungal culture and identification，antigen and antibody determinations and molecular biological determination.

Key words: Invasive fungus, Infection, Candida, Cryptococcus, Aspergillus, Diagnosis

CLC Number:

R446.1

WANG Dongjiang, GUO Jian. Advance in laboratory diagnosis of invasive fungal infection[J]. Laboratory Medicine, 2023, 38(2): 179-185.

References 37

[1]	BONGOMIN F, GAGO S, OLADELE R O, et al. Global and multi-national prevalence of fungal diseases-estimate precision[J]. J Fungi(Basel), 2017, 3(4):57.
[2]	KAUR H, CHAKRABARTI A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries[J]. J Fungi(Basel), 2017, 3(3):41.
[3]	DIGNANI M C. Epidemiology of invasive fungal diseases on the basis of autopsy reports[J]. F1000Prime Rep, 2014, 6:81.
[4]	BENEDICT K, JACKSON B R, CHILLER T, et al. Estimation of direct healthcare costs of fungal diseases in the United States[J]. Clin Infect Dis, 2019, 68(11):1791-1797. DOI PMID
[5]	SPIVAK E S, HANSON K E. Candida auris:an emerging fungal pathogen[J]. J Clin Microbiol, 2018, 56(2):e01588-17.
[6]	ÖZENCI V, KLINGSPOR L, ULLBERG M, et al. Estimated burden of fungal infections in Sweden[J]. Mycoses, 2019, 62(11):1043-1048. DOI PMID
[7]	DONNELLY J P, CHEN S C, KAUFFMAN C A, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium[J]. Clin Infect Dis, 2020, 71(6):1367-1376. DOI PMID
[8]	VECCHIONE A, FLORIO W, CELANDRONI F, et al. Comparative evaluation of six chromogenic media for presumptive yeast identification[J]. J Clin Pathol, 2017, 70(12):1074-1078. DOI PMID
[9]	曹楠楠, 林雅慧, 司徒博, 等. 不同方法鉴定临床常见念珠菌性能评价[J]. 广东医学, 2021, 42(8):914-919.
[10]	CASSAGNE C, NORMAND A C, L'OLLIVIER C, et al. Performance of MALDI-TOF MS platforms for fungal identification[J]. Mycoses, 2016, 59(11):678-690. DOI PMID
[11]	KARAGEORGOPOULOS D E, VOULOUMANOU E K, NTZIORA F, et al. β-D-glucan assay for the diagnosis of invasive fungal infections:a meta-analysis[J]. Clin Infect Dis, 2011, 52(6):750-770. DOI URL
[12]	中国侵袭性真菌感染工作组. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第五次修订版)[J]. 中华内科杂志, 2017, 56(6):453-459.
[13]	刘利华, 李建美, 董海新, 等. 支气管肺泡灌洗液GM试验联合血清GM试验对侵袭性肺曲霉病的诊断价值[J]. 中华危重病急救医学, 2019, 31(3):331-335.
[14]	HELDT S, HOENIGL M. Lateral flow assays for the diagnosis of invasive aspergillosis:current status[J]. Curr Fungal Infect Rep, 2017, 11(2):45-51. DOI URL
[15]	DICHTL K, FORSTER J, ORMANNS S, et al. Comparison of β-D-glucan and galactomannan in serum for detection of invasive aspergillosis:retrospective analysis with focus on early diagnosis[J]. J Fungi (Basel), 2020, 6(4):253.
[16]	MARR K A, DATTA K, MEHTA S, et al. Urine antigen detection as an aid to diagnose invasive aspergillosis[J]. Clin Infect Dis, 2018, 67(11):1705-1711. DOI PMID
[17]	LI Z, WANG M, ZENG P, et al. Examination of a Chinese-made cryptococcal glucuronoxylomannan antigen test in serum and bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients[J]. J Microbiol Immunol Infect, 2022, 55(2):307-313. DOI URL
[18]	陈栎江, 吴庆, 徐春泉, 等. 血清隐球菌荚膜多糖抗原检测在肺隐球菌病中的早期诊断价值[J]. 中国抗生素杂志, 2018, 43(10):1248-1251.
[19]	吕晓东, 周玲, 郭珍, 等. 恶性血液病患者侵袭性念珠菌病中1,3-β-D葡聚糖、甘露聚糖及其抗体联合检测的临床价值[J]. 郑州大学学报(医学版), 2018, 53(1):84-88.
[20]	HELD J, KOHLBERGER I, RAPPOLD E, et al.Comparison of(1->3)-beta-D-glucan,mannan/anti-mannan antibodies,and Cand-Tec Candida antigen as serum biomarkers for candidemia[J]. J Clin Microbiol, 2013, 51(4):1158-1164. DOI URL
[21]	张建. 血清β-D葡聚糖、半乳甘露聚糖、Cand-Tec抗原检测在侵袭性真菌病诊断中的应用价值[J]. 陕西医学杂志, 2019, 48(1):125-127.
[22]	杨罗曼, 周庆涛, 贺蓓. 抗体检测在侵袭性念珠菌病诊断中的价值[J]. 中华结核和呼吸杂志, 2019, 42(11):868-872.
[23]	HAMMARSTRÖM H, STJÄRNE ASPELUND A, CHRISTENSSON B, et al. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients[J]. Mycoses, 2018, 61(9):623-632. DOI PMID
[24]	AZAR M M, HAGE C A. Laboratory diagnostics for histoplasmosis[J]. J Clin Microbiol, 2017, 55(6):1612-1620. DOI PMID
[25]	VIDAL-GARCÍA M, DOMINGO M P, DE RUEDA B, et al. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis[J]. Appl Microbiol Biotechnol, 2016, 100(5):2327-2334. DOI URL
[26]	MERCIER T, RESÉNDIZ SHARPE A, WAUMANS D, et al. Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosis[J]. Mycoses, 2019, 62(10):945-948. DOI PMID
[27]	PARRA-SÁNCHEZ M, ZAKARIYA-YOUSEF BREVAL I, CASTRO MÉNDEZ C, et al. Candida albicans germ-tube antibody:evaluation of a new automatic assay for diagnosing invasive candidiasis in ICU patients[J]. Mycopathologia, 2017, 182(7-8):645-652. DOI URL
[28]	CLANCY C J, NGUYEN M H. Diagnosing invasive candidiasis[J]. J Clin Microbiol, 2018, 56(5):e01909-e01917.
[29]	DUETTMANN W, KOIDL C, KRAUSE R, et al. Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection[J]. Mycoses, 2016, 59(6):374-378. DOI PMID
[30]	LI F Q, MA C F, SHI L N, et al. Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia[J]. BMC Infect Dis, 2013, 13:253. DOI URL
[31]	ULLMANN A J, AGUADO J M, ARIKAN-AKDAGLI S, et al. Diagnosis and management of Aspergillus diseases:executive summary of the 2017 ESCMID-ECMM-ERS guideline[J]. Clin Microbiol Infect, 2018, 24(Suppl 1):e1-e38.
[32]	WHITE P L, BRETAGNE S, CALIENDO A M, et al. Aspergillus polymerase chain reaction-an update on technical recommendations,clinical applications,and justification for inclusion in the second revision of the EORTC/MSGERC definitions of invasive fungal disease[J]. Clin Infect Dis, 2021, 72(Suppl 2):S95-S101. DOI URL
[33]	SALIMNIA H, FAIRFAX M R, LEPHART P R, et al. Evaluation of the FilmArray blood culture identification panel:results of a multicenter controlled trial[J]. J Clin Microbiol, 2016, 54(3):687-698. DOI URL
[34]	IBÁÑEZ-MARTÍNEZ E, RUIZ-GAITÁN A, PEMÁN-GARCÍA J. Update on the diagnosis of invasive fungal infection[J]. Rev Esp Quimioter, 2017, 30(Suppl 1):16-21.
[35]	LI Y, FAN P, ZHOU S, et al. Loop-mediated isothermal amplification(LAMP):a novel rapid detection platform for pathogens[J]. Microb Pathog, 2017, 107:54-61. DOI URL
[36]	谢栓栓, 李譞, 李萍, 等. 宏基因二代测序技术对感染性疾病患者的诊断价值及其临床应用[J]. 国际呼吸杂志, 2020, 40(9):641-646.
[37]	HAN D, LI Z, LI R, et al. mNGS in clinical microbiology laboratories:on the road to maturity[J]. Crit Rev Microbiol, 2019, 45(5-6):668-685. DOI URL